Article

Visual impairment more common in people with diabetes, study says

Visual impairment may be more common in people with diabetes than in those without the disease, according to a study in the Archives of Ophthalmology.

Atlanta-Visual impairment may be more common in people with diabetes than in those without the disease, according to a study in the Archives of Ophthalmology.

About 14.6 million Americans had diagnosed diabetes mellitus in 2005 and another 6.2 million had undiagnosed diabetes, according to background information in the article. It is estimated that the number of individuals with diagnosed diabetes will increase to 48.3 million by 2050.

"Diabetic retinopathy, one of the most common microvascular complications of diabetes, is considered to be one of the major causes of blindness and low vision," the authors write.

Although studies suggest that controlling glucose and blood pressure have reduced the rate of retinal diseases, other ocular conditions suffered by diabetic patients, such as cataract and glaucoma, may increase the risk of visual impairment.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.